Journal articleBr J Cancer2017
Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer.
- Journal
- Br J Cancer
- Published
- 12 January 2017
- Citations
- 23
- Type
- Article
- License
- cc by-nc-sa
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try